Biotechnology Jobs

• Opfikon, Switzerland
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.

• Opfikon, Switzerland
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs. Sits on the Therapy Area Leadership Team, co-leads New Product Opportunity reviews, engages external KOLs and investigators, and drives cross-functional due diligence with BD to close deals.

• Cambridge
• Hybrid · 3 days in office
• Lead · manages people
• Permanent

Accountable to the Global Clinical Head for an indication-aligned cluster of late-phase Respiratory and Immunology studies, supervising Global Development Medical Directors and Scientist Directors. Leads cross-functional design, conduct, monitoring and data interpretation, represents the program at health authority interactions, and co-leads publication strategy.

• Waltham, United States
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.

• London
• Hybrid
• US$204,000 – US$340,000 pa
• Director

Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.

• Uxbridge
• Director

Serves as primary medical accountability for multiple Phase 1-3 clinical trials in GI oncology, leading medical data review, safety assessment and site interactions within a Study Delivery Team. Partners with Clinical Scientists on protocol design, benefit/risk analysis and health authority interactions, while building relationships with principal investigators and thought leaders.

• London
• Hybrid
• Director
• Permanent

Lead clinical pharmacology and pharmacometrics across a growing drug discovery portfolio, serving as the quantitative lead on cross-functional project teams. Apply MIDD, PBPK, population PK/PD and QSP modelling to translate nonclinical data into human dosing and trial design, spanning small molecules, biologics and novel platforms. Also manages CRO partnerships and authors regulatory submissions.

NONMEM · R · Monolix +3

• London
• Hybrid
• £83,930 – £155,870 pa
• Director

Supports the development, launch and continuous improvement of AI-powered products, working alongside Line Function Product Owners and cross-functional teams to translate product vision and strategy. Manages the product lifecycle from MVP through scaling, tracking budget and value metrics, and collaborating with DDIT and external parties on delivery and handover to maintenance.

Pandas · R

• Hyderabad, India
• On-site
• Director · manages people

Acts as the primary interface between business stakeholders, biostatisticians, statistical programmers and technical delivery teams, translating clinical and statistical requirements into scalable R-based analytics, automation workflows and enterprise reporting. Leads requirement workshops, manages a small team, and oversees releases with end-to-end traceability, regulatory compliance and audit readiness across the clinical trial lifecycle.

• Cambridge, United States
• Hybrid · 3 days in office
• Director

Lead end-to-end clinical trial material planning, vendor management, packaging, labeling, inventory and global distribution for an AI-first drug discovery company. Act as the clinical supply authority within a lean Pharmaceutical Sciences & CMC team, building scalable systems and vendor networks while partnering closely with Clinical Operations and CROs.

IRT · RTSM

• Oxford
• On-site
• Director · manages people

Lead the DMPK team at Vertex's Oxford site, shaping strategy and operations while sitting on both the Global DMPK and Oxford Site leadership teams. The role directs ADME science across discovery and development programmes, partners with Medicinal Chemistry, Biology, Preclinical Safety and Clinical Pharmacology, and oversees regulatory documentation such as INDs and marketing applications. It combines deep small-molecule DMPK expertise with hiring, mentoring and resource planning.

• Maidenhead
• Hybrid · 3 days in office
• Director · manages people

Leads scientific safety assessments for assigned medicinal products, partnering with Medical Safety Officers to prepare analyses and evaluations for regulatory compliance. Supports Safety Management Teams, conducts proactive safety data reviews, and serves as product point of contact, with hybrid working requiring three days on site.

Microsoft Word · Microsoft Excel · Microsoft PowerPoint

• Uxbridge
• Hybrid
• Director

As a member of cross-functional development teams, you will contribute to trial design, protocol development, analysis planning, and regulatory submissions, with the option to support a specific asset indication. The role involves authoring statistical analysis plans and clinical study reports, defending protocols at governance reviews, and providing statistical leadership on health authority requests. It requires 50% onsite presence in Uxbridge and proficiency in SAS, R, or Python.

SAS · R · Python

• Stevenage
• Hybrid
• Director · manages people

Accountable for onboarding and ongoing performance management of apheresis and treatment centres supporting clinical and commercial CAR T-cell therapies across the UK and Rest of World. Serves as the technical operations single point of contact, conducting site assessments, training centre staff, supporting quality systems and deviations, and managing process change rollouts. Involves up to 50% travel and possible management of contract employees.

Electronic Data Management Systems

• London
• On-site
• Director
• Permanent

Leads CMC regulatory strategy for global submissions including IND, CTA, BLA and MAA, and oversees agency correspondence and compliance for mRNA products. Reviews submissions for readiness, drives health authority interactions, and advises manufacturing and quality teams on change controls and regulatory guidance across vaccines, oncology and rare disease programmes.

IND · CTA · BLA +1